Anti-diabetes effect of water containing hydrogen molecule and Pt nanoparticles.
Sanetaka Shirahata, Takeki Hamasaki, Keisuke Haramaki, Takuro Nakamura, Masumi Abe, Hanxu Yan, Tomoya Kinjo, Noboru Nakamichi, Shigeru Kabayama, Kiichiro Teruya · BMC Proceedings · 2011
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
The study identified a possible biological mechanism for hydrogen rather than demonstrating a clinical treatment effect.
Molecular hydrogen diabetes study 2011: what the findings mean
This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. This animal study examined Anti-diabetes effect of water containing hydrogen molecule and Pt nanoparticles. The abstract describes Animal model.
How to read this paper: This is a mechanism-focused study. It investigates a biological target or pathway through which molecular hydrogen may act; it does not establish clinical benefit in people.
Publication: Sanetaka Shirahata, Takeki Hamasaki, Keisuke Haramaki, Takuro Nakamura, Masumi Abe, Hanxu Yan, Tomoya Kinjo, Noboru Nakamichi, Shigeru Kabayama, Kiichiro Teruya, BMC Proceedings, 2011.
What the researchers studied
The researchers examined how molecular hydrogen related to diabetes. The available structured record did not clearly identify one primary outcome, so the original source should be checked for the complete endpoint definitions.
What effects did molecular hydrogen have?
Observed mechanistic effect: ) and scavenges reactive oxygenspecies (ROS) to protect DNA from oxidative damage[1]. ERW exhibits anti-diabetes effectsin vitroand in vivo [4-6][7]. The finding identifies a possible biological target or pathway through which molecular hydrogen may act. It does not establish clinical benefit in people.
Why these findings matter
This research helps explain how hydrogen may act at a biological level. It strengthens the scientific rationale for future therapeutic studies, but it does not show that patients will experience a clinical benefit.
How strong is this evidence?
This is preclinical animal evidence. It can show biological effects in a whole living system, but human effectiveness and dosing still require clinical trials.
Technical study details
- Publication type: Animal study
- Evidence type: Preclinical animal evidence
- Research model or population: Animal model
- Hydrogen method: Other or not reported
Limitations and safety
Important limitations: Preclinical animal findings may not translate directly to human outcomes.
Safety information: The abstract did not provide detailed safety or adverse-event information.
Original study and H2HUBB research context
This page explains a published research record and does not turn one study into a medical recommendation. Read the original scientific source for the complete methods, statistics, and author conclusions. Compare this result with related evidence in the H2HUBB Molecular Hydrogen Research Library.